Table of Contents

2019-2024 Global Natamycin Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Natamycin Consumption 2014-2024
  • 2.1.2 Natamycin Consumption CAGR by Region
• 2.2 Natamycin Segment by Type
  • 2.2.1 Natamycin 50%
  • 2.2.2 Natamycin 95%
• 2.3 Natamycin Consumption by Type
  • 2.3.1 Global Natamycin Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Natamycin Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Natamycin Sale Price by Type (2014-2019)
• 2.4 Natamycin Segment by Application
  • 2.4.1 Food industry
  • 2.4.2 Medical
  • 2.4.3 Others
• 2.5 Natamycin Consumption by Application
  • 2.5.1 Global Natamycin Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Natamycin Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Natamycin Sale Price by Application (2014-2019)

3 Global Natamycin by Players

• 3.1 Global Natamycin Sales Market Share by Players
  • 3.1.1 Global Natamycin Sales by Players (2017-2019)
  • 3.1.2 Global Natamycin Sales Market Share by Players (2017-2019)
• 3.2 Global Natamycin Revenue Market Share by Players
  • 3.2.1 Global Natamycin Revenue by Players (2017-2019)
  • 3.2.2 Global Natamycin Revenue Market Share by Players (2017-2019)
• 3.3 Global Natamycin Sale Price by Players
• 3.4 Global Natamycin Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Natamycin Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Natamycin Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Natamycin by Regions

• 4.1 Natamycin by Regions
  • 4.1.1 Global Natamycin Consumption by Regions
  • 4.1.2 Global Natamycin Value by Regions
• 4.2 Americas Natamycin Consumption Growth
• 4.3 APAC Natamycin Consumption Growth
• 4.4 Europe Natamycin Consumption Growth
• 4.5 Middle East & Africa Natamycin Consumption Growth

5 Americas

• 5.1 Americas Natamycin Consumption by Countries
  • 5.1.1 Americas Natamycin Consumption by Countries (2014-2019)
  • 5.1.2 Americas Natamycin Value by Countries (2014-2019)
• 5.2 Americas Natamycin Consumption by Type
• 5.3 Americas Natamycin Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Natamycin Consumption by Countries
  • 6.1.1 APAC Natamycin Consumption by Countries (2014-2019)
  • 6.1.2 APAC Natamycin Value by Countries (2014-2019)
• 6.2 APAC Natamycin Consumption by Type
• 6.3 APAC Natamycin Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Natamycin by Countries
  • 7.1.1 Europe Natamycin Consumption by Countries (2014-2019)
  • 7.1.2 Europe Natamycin Value by Countries (2014-2019)
• 7.2 Europe Natamycin Consumption by Type
• 7.3 Europe Natamycin Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Natamycin by Countries
  • 8.1.1 Middle East & Africa Natamycin Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Natamycin Value by Countries (2014-2019)
• 8.2 Middle East & Africa Natamycin Consumption by Type
• 8.3 Middle East & Africa Natamycin Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Natamycin Distributors
• 10.3 Natamycin Customer

11 Global Natamycin Market Forecast

• 11.1 Global Natamycin Consumption Forecast (2019-2024)
• 11.2 Global Natamycin Forecast by Regions
  • 11.2.1 Global Natamycin Forecast by Regions (2019-2024)
  • 11.2.2 Global Natamycin Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Natamycin Forecast by Type
• 11.8 Global Natamycin Forecast by Application

12 Key Players Analysis

• 12.1 Danisco
  • 12.1.1 Company Details
  • 12.1.2 Natamycin Product Offered
  • 12.1.3 Danisco Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Danisco News
• 12.2 DSM
  • 12.2.1 Company Details
  • 12.2.2 Natamycin Product Offered
  • 12.2.3 DSM Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 DSM News
• 12.3 VGP
  • 12.3.1 Company Details
  • 12.3.2 Natamycin Product Offered
  • 12.3.3 VGP Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 VGP News
• 12.4 Handary
  • 12.4.1 Company Details
  • 12.4.2 Natamycin Product Offered
  • 12.4.3 Handary Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Handary News
• 12.5 AMTECH BIOTECH
  • 12.5.1 Company Details
  • 12.5.2 Natamycin Product Offered
  • 12.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 AMTECH BIOTECH News
• 12.6 Silver-Elephant
  • 12.6.1 Company Details
  • 12.6.2 Natamycin Product Offered
  • 12.6.3 Silver-Elephant Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Silver-Elephant News
• 12.7 Lanzhou Weiri
  • 12.7.1 Company Details
  • 12.7.2 Natamycin Product Offered
  • 12.7.3 Lanzhou Weiri Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Lanzhou Weiri News
• 12.8 Langfang Meihua
  • 12.8.1 Company Details
  • 12.8.2 Natamycin Product Offered
  • 12.8.3 Langfang Meihua Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Langfang Meihua News
• 12.9 Zhengzhou New Frey
  • 12.9.1 Company Details
  • 12.9.2 Natamycin Product Offered
  • 12.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Zhengzhou New Frey News
• 12.10 Chihon
  • 12.10.1 Company Details
  • 12.10.2 Natamycin Product Offered
  • 12.10.3 Chihon Natamycin Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Chihon News
• 12.11 Jiaozuo Joincare
• 12.12 Beijing Oriental Rada
• 12.13 Pucheng Lifecome

13 Research Findings and Conclusion

Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Raw Materials are important component, occupying for the most proportion of cost. It’s important and necessary to attach importance to raw materials sourcing.
In general, the raw materials need to outsourcing, and the price, on-time rate and quality are very key indicators, to keep competitive market position, to maximize the profit.

Actually, the price, on-time rate or quality, is just one of key factors to influence on the supply capacity and competitiveness. The lowest total production cost is the total index to maximize the profit.

To a producer, can control the total production cost through worldwide procurement, localization procurement and concentrative purchase, more purchasing focuses on fewer suppliers to large-scale purchase, to large-scale and high efficiency. Now the logistics and information is well-developed, beneficial to worldwide procurement, localization procurement and concentrative purchase. In future, more manufacturers will attach importance to the raw materials purchasing,
Consumers are generally quick-change, to get or use newfangled products, better experience, better convenience and more quicker; to find and meet the needs of consumers, and exceeding expectation, better service. The world changes quickly, especially in mobile internet and consumer electronics, and now the mobile internet and consumer electronics are changing the traditional sectors, to more efficient, more cheaper and powerful.

According to this study, over the next five years the Natamycin market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Natamycin business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Natamycin market by product type, application, key manufacturers and key regions and countries.

This study considers the Natamycin value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Natamycin 50%
Natamycin 95%
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Food industry
Medical
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Natamycin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Natamycin market by identifying its various subsegments.
Focuses on the key global Natamycin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Natamycin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Natamycin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.